The global knee-assist exosuit market, valued at $1.8 billion in 2025, is projected to nearly triple to $5.2 billion by 2034, according to Dataintelo. The substantial expansion reflects current knee-assist exosuit market trends, particularly the dominance of soft exosuits in medical rehabilitation. Asia Pacific leads regional growth, accounting for 36.0% of global revenues in 2025.

The knee-assist exosuit market is set for massive expansion, but its specific, high-impact segments and regional drivers remain largely under the radar for many. Investors often overlook the nuanced preferences driving this growth, focusing instead on broader market figures.

Based on current projections and segment dominance, companies and investors who strategically target soft exosuits for medical rehabilitation in the Asia Pacific region are likely to capture the lion's share of this burgeoning market.

What We Know About Knee-Assist Exosuit Market Growth

  • Soft exosuits held the largest product type share at 58.4% in 2025, according to knee-assist exosuit market research report 2034.
  • Medical Rehabilitation was the leading application segment, holding a 36.7% share in 2025, according to knee-assist exosuit market research report 2034.
  • Asia Pacific generated $648 million in regional revenue in 2025, representing 36.0% of global revenues, according to knee-assist exosuit market research report 2034.
  • The global knee-assist exosuit market is projected to reach $5.2 billion by 2034, according to knee-assist exosuit market research report 2034.

Dominance of Soft Exosuits in Rehabilitation

Soft exosuits, with their 58.4% market share in 2025, demonstrate a clear preference for less invasive and more comfortable therapeutic assistance. The 58.4% market share of soft exosuits in 2025, combined with medical rehabilitation's 36.7% application share, indicates that the market prioritizes flexible, lightweight devices over more rigid, heavy-duty exoskeletons.

This overwhelming dominance suggests that the overall market growth is significantly skewed. Other exosuit types or applications appear to be growing at a much slower pace, or even stagnating, making the headline growth figures potentially misleading for diversified investors.